Serine biosynthesis as a novel therapeutic target for dilated cardiomyopathy.
Sign Up to like & getrecommendations! Published in 2022 at "European heart journal"
DOI: 10.1093/eurheartj/ehac305
Abstract: AIMS Genetic dilated cardiomyopathy (DCM) is a leading cause of heart failure. Despite significant progress in understanding the genetic aetiologies of DCM, the molecular mechanisms underlying the pathogenesis of familial DCM remain unknown, translating to… read more here.
Keywords: serine biosynthesis; ipsc cms; dcm ipsc; dcm ... See more keywords